Condition

Normal Pressure Hydrocephalus

ClinicalTrials.gov condition label

Clinical trials7

Recruiting2

Common interventions6

Lead sponsors shown6

Clinical trials

7 shown

Proteinopathies Expression in Skin of Neurodegenerative DisordersNCT06528964 · 2023-12-20

Neurosurgical Outcome NetworkNCT06724029 · 2022-12-05

A Pilot Biomarker Study Assessing Alpha-synuclein Aggregates Across Biofluid Reservoirs in Patients With SynucleinopathiesNCT04020198 · 2020-01-15

Brain Network Activation in Patients With Movement DisordersNCT03269201 · 2019-03-01

Neurology Inpatient Clinical Education TrialNCT03826056 · 2019-02-01

Positron Emission Tomography Imaging of Brain Amyloid in Normal Pressure HydrocephalusNCT01092546 · 2010-03-01

PET Imaging of Brain Amyloid in Normal Pressure HydrocephalusNCT01053312 · 2009-12-01

Common interventions

[18F] FlutemetamolDRUG1 [18F]FlutemetamolDRUG1 Biomarker assayOTHER1 Current standard discharge educational interventionBEHAVIORAL1 Immunohistochemistry and immunofluorescenceDIAGNOSTIC_TEST1 Personalized discharge educational interventionBEHAVIORAL1

Leading sponsors

GE Healthcare2 Dartmouth-Hitchcock Medical Center1 Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta1 Sheba Medical Center1 Stony Brook University1 Universidad Autonoma de San Luis Potosí1

Trial status mix

COMPLETED2

RECRUITING2

TERMINATED2

UNKNOWN1

Phase mix

PHASE32

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.